An mRNA structure in bacteria that controls gene expression by binding lysine

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• Riboswitches are genetic elements in messenger RNA's untranslated regions that control gene expression in response to metabolite binding.
• Understanding riboswitch mechanisms is crucial for deciphering gene regulation and developing novel therapeutic strategies.

Purpose of the Study:

• To identify and characterize a novel lysine-responsive riboswitch in the 5'-UTR of the Bacillus subtilis lysC gene.
• To investigate the binding specificity and affinity of the identified riboswitch for L-lysine and related analogs.
• To explore the potential of this riboswitch class as a target for antimicrobial agents.

Main Methods:

• Bioinformatic analysis to identify conserved RNA elements in the 5'-UTR of the lysC gene.
• In vitro biochemical assays to determine the binding affinity (KD) of the riboswitch for L-lysine.
• Competitive binding assays using structural analogs of lysine to assess molecular discrimination.
• Testing the efficacy of S-(2-aminoethyl)-L-cysteine (AEC) as an antimetabolite targeting the riboswitch.

Main Results:

• A conserved RNA element in the 5'-UTR of Bacillus subtilis lysC functions as a lysine-riboswitch.
• The riboswitch exhibits high-affinity binding to L-lysine (KD ≈ 1 µM) and discriminates effectively against D-lysine and ornithine.
• Evidence suggests that this riboswitch class is a target for the antimetabolite S-(2-aminoethyl)-L-cysteine (AEC).

Conclusions:

• Direct metabolite sensing by messenger RNA via riboswitches is a fundamental mechanism of genetic control.
• Lysine-riboswitches represent a promising new class of antimicrobial drug targets, particularly against bacteria.
• The findings support the broader hypothesis that riboswitches are essential regulators and potential therapeutic targets.